Andrew Côté is not your typical tech event organizer. An engineering physicist with a background in nuclear fusion, plasma physics, large language models for drug discovery (before LLMs were a thing) and robotics, he has quickly become a maverick in the deep tech ecosystem.
Scaling bioprocesses is “notoriously slow and prohibitively expensive,” says Differential Bio CEO Christian Spier. “We’re here to change that.”
Subscribe to the industry’s top headlines from the pages of AgFunderNews that week, as well as a roundup of global media coverage, a list of job openings in the sector, and alerts about our latest research reports.
By clicking Sign Up you’re confirming that you agree with our Terms and Conditions.
Sign up for our weekly newsletter.
